Literature DB >> 14734774

Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein.

Byung Oh Kim1, Ying Liu, Betty Y Zhou, Johnny J He.   

Abstract

HIV-1 Tat has been proposed as a key agent in many AIDS-related disorders, including HIV-1-associated neurological diseases. We have recently shown that Tat expression induces a significant increase in T lymphocytes in the brains of Tat transgenic mice. The CNS infiltration of T lymphocytes has been noted in AIDS patients. In the present study using this unique genetic system we attempted to understand the underlying mechanisms of Tat expression-induced infiltration of T lymphocytes by examining chemokine expression. RNase protection assay revealed that in addition to CCL2 (monocyte chemoattractant protein-1), CCL3 (macrophage inflammatory protein-1alpha (MIP-1alpha)), CCL4 (MIP-1beta), CCL5 (RANTES), CXCL2 (MIP-2), and CXCL10 (inducing protein-10), XCL1 (lymphotactin/single C motif-1alpha/activation-induced, T cell-derived and chemokine-related cytokine) was identified to be up-regulated by Tat expression. XCL1 is a C chemokine and plays a specific and important role in tissue-specific recruitment of T lymphocytes. Thus, we further determined the relationship between Tat and XCL1 expression. Tat-induced XCL1 expression was further confirmed by XCL1-specific RT-PCR and ELISA. Combined in situ hybridization and immunohistochemical staining identified astrocytes, monocytes, and macrophages/microglia as XCL1-producing cells in vivo. Using human astrocytes, U87.MG cells, as an in vitro model, activation of XCL1 expression was positively correlated with Tat expression. Moreover, the XCL1 promoter-driven reporter gene assay showed that Tat-induced XCL1 expression occurred at the transcriptional level. Taken together, these results demonstrate that Tat directly trans-activated XCL1 expression and suggest potential roles of Tat-induced XCL1 expression in the CNS infiltration of T lymphocytes during HIV-1 infection and subsequent HIV-1-induced neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734774     DOI: 10.4049/jimmunol.172.3.1888

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.

Authors:  Dianne Langford; Byung Oh Kim; Wei Zou; Yan Fan; Pejman Rahimain; Ying Liu; Johnny J He
Journal:  J Neurovirol       Date:  2017-11-15       Impact factor: 2.643

2.  Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target.

Authors:  Runxia Liu; Yang-Hui Jimmy Yeh; Ales Varabyou; Jack A Collora; Scott Sherrill-Mix; C Conover Talbot; Sameet Mehta; Kristen Albrecht; Haiping Hao; Hao Zhang; Ross A Pollack; Subul A Beg; Rachela M Calvi; Jianfei Hu; Christine M Durand; Richard F Ambinder; Rebecca Hoh; Steven G Deeks; Jennifer Chiarella; Serena Spudich; Daniel C Douek; Frederic D Bushman; Mihaela Pertea; Ya-Chi Ho
Journal:  Sci Transl Med       Date:  2020-05-13       Impact factor: 17.956

3.  Expressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitis.

Authors:  Po-Ting Yeh; Feng-An Lin; Chang-Pin Lin; Chung-May Yang; Muh-Shy Chen; Chang-Hao Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-29       Impact factor: 3.117

4.  Analytical workflow profiling gene expression in murine macrophages.

Authors:  Scott E Nixon; Dianelys González-Peña; Marcus A Lawson; Robert H McCusker; Alvaro G Hernandez; Jason C O'Connor; Robert Dantzer; Keith W Kelley; Sandra L Rodriguez-Zas
Journal:  J Bioinform Comput Biol       Date:  2015-01-14       Impact factor: 1.122

5.  In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.

Authors:  Xi-Ling Sheng; Hao Zhang
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

6.  Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.

Authors:  Stephen Correia; Ronald Cohen; Assawin Gongvatana; Skye Ross; James Olchowski; Kathryn Devlin; Karen Tashima; Bradford Navia; Suzanne Delamonte
Journal:  J Neuroimmunol       Date:  2013-09-27       Impact factor: 3.478

7.  Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

Authors:  Erinn S Raborn; Guy A Cabral
Journal:  J Pharmacol Exp Ther       Date:  2010-01-20       Impact factor: 4.030

8.  Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.

Authors:  Adrian G Rosas-Taraco; David M Higgins; Joaquín Sánchez-Campillo; Eric J Lee; Ian M Orme; Mercedes González-Juarrero
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

Review 9.  Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases.

Authors:  Egle Cekanaviciute; Marion S Buckwalter
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

10.  Cannabinoid receptor-2 and HIV-associated neurocognitive disorders.

Authors:  Vishnudutt Purohit; Rao S Rapaka; Joni Rutter
Journal:  J Neuroimmune Pharmacol       Date:  2014-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.